Alprazolam

Epilepsy

UCB Biopharma SRLSmall moleculePhase 2Dormant

B

60/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 52/ 100
Competitive Position: 73/ 100

Competitive context

65 Active assets in the Epilepsy cohort.

Asset / Sponsor	Phase	Rating
Lamotrigine Assiut University	Phase 4	BBB
Eslicarbazepine Acetate Bial - Portela C S.A.	Phase 4	BBB
Lacosamide Second Affiliated Hospital of Guangzhou Medical University	Phase 4	BBB
Levetiracetam Beijing Tiantan Hospital	Phase 4	BBB
Topiramate Université de Sherbrooke	Phase 4	BBB

View all 50 →

Same molecule, other indications

Alprazolam is also rated in:

anxiety disorderDormant

BB

Indicative · Phase 3

66 / 100

physiological malfunction arising from mental factorDormant

B

Indicative · Phase 3

60 / 100

dementiaDormant

B

Indicative · Phase 3

57 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.